BEXTRA Lawyers - Side Effects, Recall, Lawsuit
  HOME   ABOUT US   BEXTRA RESOURCES   FAQ's BEXTRA NEWS CONTACT US July 29, 2010
Small Business Lawyers Image
 
 
Selecting an attorney for your legal case is a very important decision. Please enter a zip code to find an attorney in your area:
 
  More Product Liability
 

Stevens-Johnson Syndrome (Erythema multi...


< Back to Previous Page

Article Summary: Bextra has been linked to Stevens Johnson Syndrome (Erythema Multiforme) which is a skin disorder resulting from an allergic reaction.

Stevens-Johnson Syndrome (Erythema multiforme) A Side Effect of Bextra 

Erythema multiforme

   
Alternative names   
Lyell's syndrome; Stevens-Johnson syndrome; Toxic epidermal necrolysis

Definition   
Erythema multiforme is a skin disorder resulting from an allergic reaction.

Causes, incidence, and risk factors   
Erythema multiforme is a type of hypersensitivity (allergic) reaction that occurs in response to medications, infections, or illness. Medications associated with erythema multiforme include sulfonamides, penicillins, barbiturates, and phenytoin. Associated infections include herpes simplex and mycoplasma infections.

The exact cause is unknown. The disorder is believed to involve damage to the blood vessels of the skin with subsequent damage to skin tissues. Approximately 90% of erythema multiforme cases are associated with herpes simplex or Mycoplasma infections. The disorder occurs primarily in children and young adults.

Erythema multiforme may present with a classic skin lesion with or without systemic (whole body) symptoms. In Stevens-Johnson syndrome, the systemic symptoms are severe and the lesions are extensive, involving multiple body areas (especially the mucous membranes). Toxic epidermal necrolysis (TEN syndrome, or Lyell's syndrome) involves multiple large blisters (bullae) that coalesce, followed by sloughing of all or most of the skin and mucous membranes.

Symptoms   
Skin lesion
Multiple
With sudden onset, may recur
May spread
May appear as nodule, papule, or macule
Central lesion surrounded by concentric rings of pallor and redness ("target", "iris", "bull's eye" shape)
May have vesicles and bullae (blisters of various sizes)
Located on the legs, arms, palms, hands, or feet
May involve the face or lips
Trunk is usually not involved
Usually symmetrical
Itching of the skin may be present
Fever
General ill feeling
Joint aches
Additional symptoms that may be associated with this disease:
Vision abnormalities
Dry eyes
Bloodshot eyes
Eye pain
Eye burning, itching and discharge
Mouth sores

Signs and tests   
The diagnosis is primarily based on the appearance of the skin lesion and its typical symmetrical distribution, especially if there is a history of risk factors or associated diseases.

There may be a positive Nikolsky's sign.

A skin lesion biopsy and microscopic examination may be helpful to differentiate erythema multiforme from other disorders. Erythema multiforme may show tissue death and other changes. Microscopic examination of the tissue may also show antibody deposits.

Treatment   
Treatment goals include control of the underlying causes or illnesses, treatment of the symptoms, and prevention of infection. Suspected medications should be discontinued.

Treatment of mild symptoms may include:
Moist compresses applied to skin lesions.
Medications such as antihistamines to control itching.
Over-the-counter medications (such as acetaminophen) to reduce fever and discomfort.
Topical anesthetics (especially for mouth lesions) to ease discomfort that interferes with eating and drinking.
Treatment of severe symptoms may include:

Hospitalization and treatment in an intensive care or burn care unit for severe cases, Stevens-Johnson syndrome, and toxic epidermal necrolysis
Systemic corticosteroids to control inflammation
Intravenous immunoglobulins (IVIG) to stop the process
Antibiotics to control secondary skin infections
Good hygiene and isolation from others may be required to prevent secondary infections.

Extensive skin involvement may cause the loss of large quantities of body fluids, causing shock in addition to the risk of infection. Intensive care with support of body systems may be required.

Skin grafting may be helpful in cases in which large areas of the body are affected.

In cases that are caused by the herpes virus, daily antiviral medications may be prescribed to prevent recurrences of erythema multiforme.

Expectations (prognosis)   
Mild forms of erythema multiforme usually resolve without difficulty in 2 to 6 weeks, but they may recur. More severe forms may be difficult to treat. Stevens-Johnson syndrome and toxic epidermal necrolysis are associated with high death rates.
Complications    Return to top

Permanent skin damage and scarring
Occasionally, lesions on internal organs causing:
Pneumonitis (lung inflammation)
Myocarditis (heart inflammation)
Nephritis (kidney inflammation)
Hepatitis (liver inflammation)
Secondary skin infection (cellulitis)
Systemic infection, sepsis
Loss of body fluids, shock

Calling your health care provider   
Go to the emergency room or call the local emergency number (such as 911) if symptoms indicate erythema multiforme. Involvement of a large area of the body is an emergency situation.

Update Date: 4/15/2003

If you or anyone you know has taken BEXTRA and has experienced the above symptoms or side effects, contact our BEXTRA lawyer and receive a free case evaluation.

 

Latest Bextra News
 
People Who Have Survived A First Heart Attack Have A Higher Risk Of Dying
forwomen.gov, Jun 22, 2006
Cox-2 inhibitors and NSAIDs have been caught in a prolonged furor since September 2004, when the cox-2 Vioxx was withdrawn from the market due to concerns about...
Read more >

Drug Recall On Bextra
ben.omb.delaware.gov, May 24, 2006
Pfizer announced that it has voluntarily stopped the sales of Bextra...
Read more >

More Bextra News & Articles >


 
Regional Resources
 
Search for BEXTRA resources in your State:

Alabama
Missouri
Alaska Montana
Arizona Nebraska
Arkansas Nevada
California New Hampshire
Colorado New Jersey
Connecticut New Mexico
DC New York
Delaware North Carolina
Florida North Dakota
Georgia Ohio
Hawaii Oklahoma
Idaho Oregon
Illinois Pennsylvania
Indiana Rhode Island
Iowa South Carolina
Kansas South Dakota
Kentucky Tennessee
Lousiana Texas
Maine Utah
Maryland Vermont
Mass Virginia
Michigan Washington
Minnesota West Virginia
Mississippi Wisconsin
  Wyoming

Browse Map >
 
     
 
Bextra Hot Topics
 
Bextra Warning
FDA: Bextra Label Update
Bextra® Product Details
Stevens-Johnson Syndrome
Osteoarthritis Information
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Primary Dysmenorrhea
Toxic Epidermal Necrolysis


 
  Bextra Resources  
 
FAQs About Bextra
Recommended Bextra Links
Bextra Audio & Videos
Top 500 Brand Drugs
The US Federal Code
Bextra Laws

More Bextra Resources >

 
  Did You Know?  
   
 
 


Legal Disclaimers

All attorney listings are a paid attorney advertisement, and do not in any way constitute a referral or endorsement by an approved or authorized lawyer referral service. The information provided on BEXTRA Recalls.com is not intended to be legal advice, but merely conveys general information related to legal issues commonly encountered. Your access to and use of this website is subject to additional Terms and Conditions.

Local Professional? Generate new business today
Call 866-227-9356 or contact a sales rep


This site is part of the LawFirms.com Network
©2010 ExpertHub, wholly owned subsidiary of MoxyMedia, Inc.